Poorer Baseline Performance Status Is Associated With Increased VTE Risk in Metastatic Cancer Patients Treated With Immunotherapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Poorer Baseline Performance Status Is Associated With Increased Thromboembolism Risk in Metastatic Cancer Patients Treated With Immunotherapy
Support Care Cancer 2021 Mar 11;[EPub Ahead of Print], DC Guven, MS Aksun, TK Sahin, OH Aktepe, HC Yildirim, H Taban, F Ceylan, N Kertmen, Z Arik, O Dizdar, S Kilickap, S Aksoy, S Yalcin, M ErmanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.